Tracking an FDA advisory panel’s review of the Moderna Covid-19 vaccine
An expert panel is meeting Thursday to consider whether the Food and Drug Administration should issue a second emergency use authorization for a Covid-19 vaccine, this one made by Moderna.
It is almost a foregone conclusion that it will. But the hearing still promises to tell us more about the vaccine and its use.
Read Original Article: Tracking an FDA advisory panel’s review of the Moderna Covid-19 vaccine »
